The Journal of Immunology, Vol 159, Issue 11 5457-5462, Copyright © 1997 by American Association of Immunologists

ARTICLES

The DMB promoter: delineation, in vivo footprint, trans-activation, and trans-dominant suppression

JP Ting, KL Wright, KC Chin, WJ Brickey and G Li
Lineberger Comprehensive Cancer Center and Department of Microbiology- Immunology, University of North Carolina, Chapel Hill 27514, USA.

The HLA-DM loci encode the heterodimeric unconventional class II MHC molecules that are coexpressed with conventional class II MHC molecules. DM molecules are essential for the proper formation and function of conventional class II MHC molecules. This report characterizes the DMB promoter both by in vivo footprint and by in vitro functional analysis and reveals a promoter structure similar to that of conventional class II MHC genes. DR-negative mutant cell lines selectively defective in the transcription factor or class II trans- activator (CIITA) were used to reveal a requirement for both these factors in DMB promoter activation. Complementation of defective cell lines with the appropriate transcription factor reconstituted DMB promoter activation. Further analysis with CIITA identified several mutant forms of CIITA that are trans-dominant-negative mutants, i.e., they suppressed DMB promoter activation by transfected and endogenous CIITA. These mutants may be used in abiological setting to down- regulate the function of DM in Ag processing.

This article has been cited by other articles:

				A. Muhlethaler-Mottet, M. Krawczyk, K. Masternak, C. Spilianakis, A. Kretsovali, J. Papamatheakis, and W. Reith The S Box of Major Histocompatibility Complex Class II Promoters Is a Key Determinant for Recruitment of the Transcriptional Co-activator CIITA J. Biol. Chem., September 24, 2004; 279(39): 40529 - 40535. [Abstract] [Full Text] [PDF]

				U. M. Nagarajan, J. Lochamy, X. Chen, G. W. Beresford, R. Nilsen, P. E. Jensen, and J. M. Boss Class II Transactivator Is Required for Maximal Expression of HLA-DOB in B Cells J. Immunol., February 15, 2002; 168(4): 1780 - 1786. [Abstract] [Full Text] [PDF]

				R. E. Kiernan, S. Emiliani, K. Nakayama, A. Castro, J. C. Labbe, T. Lorca, K.-i. Nakayama, and M. Benkirane Interaction between Cyclin T1 and SCFSKP2 Targets CDK9 for Ubiquitination and Degradation by the Proteasome Mol. Cell. Biol., December 1, 2001; 21(23): 7956 - 7970. [Abstract] [Full Text] [PDF]

				P. Louis-Plence, S. Kerlan-Candon, J. Morel, B. Combe, J. Clot, V. Pinet, and J.-F. Eliaou The Down-Regulation of HLA-DM Gene Expression in Rheumatoid Arthritis Is Not Related to Their Promoter Polymorphism J. Immunol., November 1, 2000; 165(9): 4861 - 4869. [Abstract] [Full Text] [PDF]

				J. A. Harton and J. P.-Y. Ting Class II Transactivator: Mastering the Art of Major Histocompatibility Complex Expression Mol. Cell. Biol., September 1, 2000; 20(17): 6185 - 6194. [Full Text]

				Y. Itoh-Lindstrom, J. F. Piskurich, N. J. Felix, Y. Wang, W. J. Brickey, J. L. Platt, B. H. Koller, and J. P.-Y. Ting Reduced IL-4-, Lipopolysaccharide-, and IFN-{gamma}-Induced MHC Class II Expression in Mice Lacking Class II Transactivator Due to Targeted Deletion of the GTP-Binding Domain J. Immunol., September 1, 1999; 163(5): 2425 - 2431. [Abstract] [Full Text] [PDF]

				J. F. Piskurich, M. W. Linhoff, Y. Wang, and J. P.-Y. Ting Two Distinct Gamma Interferon-Inducible Promoters of the Major Histocompatibility Complex Class II Transactivator Gene Are Differentially Regulated by STAT1, Interferon Regulatory Factor 1, and Transforming Growth Factor beta Mol. Cell. Biol., January 1, 1999; 19(1): 431 - 440. [Abstract] [Full Text] [PDF]

				K. L. Wright, K.-C. Chin, M. Linhoff, C. Skinner, J. A. Brown, J. M. Boss, G. R. Stark, and J. P.-Y. Ting CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo PNAS, May 26, 1998; 95(11): 6267 - 6272. [Abstract] [Full Text] [PDF]